How do their growth rates compare?

Lunit has a month-over-month growth rate of -12.8%; Pollo AI has -9.6%.

How does pricing compare?

Lunit: Contact for Pricing. Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered. Pollo AI: Freemium. Freemium with a free credit allowance; paid subscription tiers add credits, premium models, and higher generation limits (see the official pricing page for current rates).

What are alternatives to Lunit and Pollo AI?

Other tools in related categories include Higgsfield, Runway, HeyGen, Vidu, Media.io.

Lunit vs Pollo AI — Traffic (29.18K vs 6.64M), Pricing & Verdict

Open AI Tools

Lunit vs Pollo AI — Traffic (29.18K vs 6.64M), Pricing & Verdict | Open AI Tools

Side-by-Side Traffic & Specification Matrix

Dimension / Metric	Lunit	Pollo AI
Official Domain	lunit.io	pollo.ai
Pricing Model	Contact for Pricing	Freemium
Monthly Visits	29.18K (29,181)	6.64M (6,641,636)
MoM Traffic Delta	-4.3K (-12.8%)	-706.04K (-9.6%)
Primary Market & Share	🇰🇷 South Korea (58.4%)	🇯🇵 Japan (26.9%)
Direct Visits / mo	8.31K	3.06M
User Rating	4.6	4.1
Supported Platforms	Website	Website

Lunit

Medical AI for earlier cancer detection and precision oncology

Lunit INSIGHT MMG and DBT

Deep-learning analysis of 2D and 3D mammography that marks suspicious lesions to help radiologists detect breast cancer earlier and reduce missed findings.

Lunit INSIGHT CXR

Chest X-ray analysis that highlights potential abnormalities such as nodules and other findings, supporting faster triage in high-volume radiology workflows.

Lunit SCOPE IO

Tumor microenvironment analysis that quantifies tumor-infiltrating lymphocytes and immune phenotypes from pathology slides, informing immunotherapy research.

Lunit SCOPE IHC Suite

AI-assisted immunohistochemistry quantification covering HER2, PD-L1, and other markers, including uIHC and a gene-expression prediction tool for standardized scoring.

Strengths & Pros

+Clinically validated radiology AI with documented regulatory clearances and published evidence
+Covers two ends of the cancer pathway — screening detection and precision oncology biomarkers — in one vendor relationship
+Wide real-world adoption across many countries, which means integrations and workflow lessons already exist
+